Christian Lehmann Selected Research

Cannabinoid Receptors (Cannabinoid Receptor)

11/2021	Cannabinoid Receptor 1 and 2 Signaling Pathways Involved in Sepsis.
11/2019	Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice.
10/2019	Monoacylglycerol lipase inhibition as potential treatment for interstitial cystitis.
1/2018	Betacaryophyllene - A phytocannabinoid as potential therapeutic modality for human sepsis?
5/2016	GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
1/2014	Cannabinoid receptor 1 inhibition improves the intestinal microcirculation in experimental endotoxemia.
12/2012	Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis.
6/2012	Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Lehmann Research Topics

Disease

45	Sepsis (Septicemia) 12/2022 - 11/2003
30	Inflammation (Inflammations) 03/2024 - 01/2006
25	Endotoxemia 01/2021 - 01/2003
15	Infections 12/2023 - 09/2010
15	Peritonitis 01/2020 - 05/2006
10	Pain (Aches) 12/2023 - 01/2005
9	Septic Shock (Toxic Shock Syndrome) 11/2021 - 11/2003
8	Pneumonia (Pneumonitis) 03/2024 - 07/2017
6	Interstitial Cystitis (Interstitial Cystitis, Chronic) 05/2023 - 01/2019
5	Stroke (Strokes) 04/2024 - 01/2016
5	Acute Lung Injury 03/2024 - 06/2022
5	COVID-19 12/2023 - 11/2020
4	Neoplasms (Cancer) 03/2023 - 01/2016
4	Hypotension (Low Blood Pressure) 08/2019 - 03/2006
3	Ischemia 01/2020 - 01/2015
3	Necrosis 11/2018 - 01/2006
3	Critical Illness (Critically Ill) 01/2018 - 01/2007
2	Hemorrhage 03/2024 - 11/2006
2	Heart Arrest (Cardiac Arrest) 01/2023 - 10/2013
2	Cystitis 01/2023 - 01/2021
2	Ventricular Fibrillation 01/2023 - 10/2013
2	Communicable Diseases (Infectious Diseases) 09/2022 - 04/2019
2	Iron Overload 06/2022 - 01/2021
2	Uveitis 09/2019 - 06/2017
2	Postoperative Pain 01/2007 - 01/2005
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2007 - 01/2003
1	Edema (Dropsy) 03/2024
1	Pulmonary Emphysema 03/2024
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023
1	Cytokine Release Syndrome 12/2023
1	Neuroinflammatory Diseases 11/2023
1	Lung Injury 07/2023
1	Urinary Tract Infections (Urinary Tract Infection) 05/2023
1	Hallucinations (Hallucination) 01/2023
1	Disease Progression 01/2023
1	Acidosis 01/2023
1	Reperfusion Injury 01/2023

Drug/Important Bio-Agent (IBA)

16	IronIBA 07/2023 - 01/2016
14	LipopolysaccharidesIBA 03/2024 - 07/2007
13	CannabinoidsIBA 04/2024 - 01/2013
12	Chelating AgentsIBA 03/2023 - 01/2016
11	CytokinesIBA 10/2023 - 11/2003
10	EndotoxinsIBA 10/2023 - 01/2003
9	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 01/2007
8	3-hydroxypyridin-4-oneIBA 06/2022 - 01/2016
8	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2021 - 06/2012
6	Anti-Bacterial Agents (Antibiotics)IBA 09/2022 - 01/2010
6	salicylhydroxamic acid (SHAM)IBA 01/2013 - 07/2008
4	EndocannabinoidsIBA 12/2023 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2014
4	InterleukinsIBA 01/2021 - 01/2006
4	iodopravadoline (AM 630)IBA 01/2021 - 12/2012
4	SolutionsIBA 01/2019 - 05/2006
3	Analgesics (Analgesic Drugs)IBA 05/2023 - 01/2005
3	HU 308IBA 12/2022 - 12/2012
3	Interleukin-10 (Interleukin 10)IBA 01/2009 - 01/2006
3	polihexanideIBA 07/2007 - 05/2006
2	ChloridesIBA 04/2024 - 01/2016
2	CannabidiolIBA 10/2023 - 01/2016
2	Ketamine FDA LinkGeneric 01/2023 - 01/2021
2	CB2 Cannabinoid ReceptorIBA 12/2022 - 01/2016
2	Free RadicalsIBA 06/2022 - 06/2017
2	Syndecan-1 (Syndecan 1)IBA 01/2022 - 01/2019
2	Therapeutic UsesIBA 01/2021 - 01/2016
2	LigandsIBA 11/2019 - 09/2019
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2018 - 01/2018
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 11/2018 - 01/2017
2	Insulin (Novolin)FDA Link 01/2018 - 01/2016
2	Crystalloid SolutionsIBA 01/2018 - 10/2013
2	Oxygen (Dioxygen)IBA 06/2017 - 11/2016
2	EnzymesIBA 01/2017 - 01/2013
2	PhysostigmineIBA 04/2015 - 01/2014
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2013 - 11/2011
2	Protein CIBA 05/2012 - 03/2008
2	Sodium SeleniteIBA 01/2009 - 01/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2009 - 01/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2008 - 05/2006
2	Ibuprofen (Motrin)FDA LinkGeneric 07/2008 - 01/2005
2	Opioid Analgesics (Opioids)IBA 07/2008 - 01/2005
2	Factor XIII (Coagulation Factor XIII)IBA 01/2008 - 02/2006
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2008 - 02/2004
2	Proteins (Proteins, Gene)FDA Link 11/2007 - 11/2003
1	FibrinIBA 03/2024
1	COVID-19 VaccinesIBA 12/2023
1	ChemokinesIBA 10/2023
1	caryophylleneIBA 05/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2023
1	HydrogenIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 10/2022

Therapy/Procedure

15	Therapeutics 12/2023 - 11/2003
12	Stents 01/2020 - 07/2007
4	Critical Care (Surgical Intensive Care) 11/2021 - 01/2006
4	Ear Acupuncture 03/2011 - 01/2005
3	Resuscitation 01/2023 - 01/2012
3	Analgesia 03/2011 - 01/2007
2	Mechanical Ventilators (Ventilator) 03/2024 - 06/2021
2	Intravenous Administration 01/2019 - 01/2010
2	Immunotherapy 01/2017 - 01/2016
1	Length of Stay 07/2023
1	Cardiopulmonary Resuscitation (CPR) 01/2023